- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.97 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x K: POTASSIUM ION(Non-covalent)
K.2: 4 residues within 4Å:- Chain A: Q.338, D.345, Q.501, F.503
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.345, A:Q.501, A:F.503, H2O.1, H2O.4
K.6: 4 residues within 4Å:- Chain B: Q.338, D.345, Q.501, F.503
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.345, B:Q.501, B:F.503, H2O.4, H2O.7
K.10: 4 residues within 4Å:- Chain C: Q.338, D.345, Q.501, F.503
5 PLIP interactions:3 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:D.345, C:Q.501, C:F.503, H2O.8, H2O.10
K.14: 4 residues within 4Å:- Chain D: Q.338, D.345, Q.501, F.503
5 PLIP interactions:3 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:D.345, D:Q.501, D:F.503, H2O.11, H2O.14
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 5 residues within 4Å:- Chain A: D.545, N.572, E.574, G.576
- Ligands: TPP.4
3 PLIP interactions:2 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.545, A:E.574, H2O.1
MG.7: 5 residues within 4Å:- Chain B: D.545, N.572, E.574, G.576
- Ligands: TPP.8
3 PLIP interactions:2 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.545, B:E.574, H2O.4
MG.11: 5 residues within 4Å:- Chain C: D.545, N.572, E.574, G.576
- Ligands: TPP.12
3 PLIP interactions:2 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:D.545, C:E.574, H2O.8
MG.15: 5 residues within 4Å:- Chain D: D.545, N.572, E.574, G.576
- Ligands: TPP.16
3 PLIP interactions:2 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.545, D:E.574, H2O.11
- 4 x TPP: THIAMINE DIPHOSPHATE(Non-covalent)
TPP.4: 26 residues within 4Å:- Chain A: V.492, G.493, Q.494, H.495, G.518, M.520, G.544, D.545, A.546, S.547, N.572, E.574, Q.575, G.576, M.577, V.578
- Chain D: Y.108, A.109, G.110, E.134, T.157, P.160, G.161, N.164, Q.197
- Ligands: MG.3
19 PLIP interactions:16 interactions with chain A, 3 interactions with chain D- Hydrophobic interactions: A:Q.575, A:V.578, D:Y.108, D:P.160
- Hydrogen bonds: A:Q.494, A:H.495, A:G.518, A:M.520, A:D.545, A:A.546, A:S.547, A:N.572, A:G.576, A:M.577, D:Q.197
- Water bridges: A:D.545, A:D.545
- Salt bridges: A:H.495, A:H.495
TPP.8: 26 residues within 4Å:- Chain B: V.492, G.493, Q.494, H.495, G.518, M.520, G.544, D.545, A.546, S.547, N.572, E.574, Q.575, G.576, M.577, V.578
- Chain C: Y.108, A.109, G.110, E.134, T.157, P.160, G.161, N.164, Q.197
- Ligands: MG.7
19 PLIP interactions:16 interactions with chain B, 3 interactions with chain C- Hydrophobic interactions: B:Q.575, B:V.578, C:Y.108, C:P.160
- Hydrogen bonds: B:Q.494, B:H.495, B:G.518, B:M.520, B:D.545, B:A.546, B:S.547, B:N.572, B:G.576, B:M.577, C:Q.197
- Water bridges: B:D.545, B:D.545
- Salt bridges: B:H.495, B:H.495
TPP.12: 26 residues within 4Å:- Chain B: Y.108, A.109, G.110, E.134, T.157, P.160, G.161, N.164, Q.197
- Chain C: V.492, G.493, Q.494, H.495, G.518, M.520, G.544, D.545, A.546, S.547, N.572, E.574, Q.575, G.576, M.577, V.578
- Ligands: MG.11
17 PLIP interactions:14 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: C:Q.575, C:V.578, B:Y.108, B:P.160
- Hydrogen bonds: C:Q.494, C:H.495, C:G.518, C:M.520, C:D.545, C:A.546, C:S.547, C:G.576, C:M.577, B:Q.197
- Water bridges: C:N.572
- Salt bridges: C:H.495, C:H.495
TPP.16: 26 residues within 4Å:- Chain A: Y.108, A.109, G.110, E.134, T.157, P.160, G.161, N.164, Q.197
- Chain D: V.492, G.493, Q.494, H.495, G.518, M.520, G.544, D.545, A.546, S.547, N.572, E.574, Q.575, G.576, M.577, V.578
- Ligands: MG.15
17 PLIP interactions:14 interactions with chain D, 3 interactions with chain A- Hydrophobic interactions: D:Q.575, D:V.578, A:Y.108, A:P.160
- Hydrogen bonds: D:Q.494, D:H.495, D:G.518, D:M.520, D:D.545, D:A.546, D:S.547, D:N.572, D:G.576, D:M.577, A:Q.197
- Salt bridges: D:H.495, D:H.495
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Garcia, M.D. et al., Commercial AHAS-inhibiting herbicides are promising drug leads for the treatment of human fungal pathogenic infections. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-09-26
- Peptides
- Acetolactate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.97 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x K: POTASSIUM ION(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 4 x TPP: THIAMINE DIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Garcia, M.D. et al., Commercial AHAS-inhibiting herbicides are promising drug leads for the treatment of human fungal pathogenic infections. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-09-26
- Peptides
- Acetolactate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A